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Testosterone Induces Up-Regulation Of Mitochondrial Gene Expression 
In Murine C2C12 Skeletal Muscle Cells Accompanied By An Increase Of 








(1) Instituto de Investigaciones Biológicas y Biomédicas del Sur (INBIOSUR-CONICET). 
8000 Bahía Blanca, Argentina.  
 









*Address for correspondence: 
Dr. Lorena Milanesi, PhD  
Laboratorio de Química Biológica y Biología del Desarrollo 
INBIOSUR-CONICET 
San Juan 670 
8000 Bahía Blanca - Argentina 
Tel.: 54-291-459 5101, ext. 4337 
Fax: 54-291-459 5130 
E-mail: milanesi@criba.edu.ar 
 
Dr. Lucía Pronsato, PhD  
Laboratorio de Química Biológica y Biología del Desarrollo 
INBIOSUR-CONICET 
San Juan 670 
8000 Bahía Blanca - Argentina 
Tel.: 54-291-459 5101, ext. 4337 






The reduction in muscle mass and strength with age, sarcopenia, is a prevalent 
condition among the elderly, linked to skeletal muscle dysfunction and cell apoptosis. 
We demonstrated that testosterone protects against H2O2-induced apoptosis in C2C12 
muscle cells. Here, we analyzed the effect of testosterone on mitochondrial gene 
expression in C2C12 skeletal muscle cells. We found that testosterone increases mRNA 
expression of genes encoded by mitochondrial DNA, such as NADPH dehydrogenase 
subunit 1 (ND1), subunit 4 (ND4), cytochrome b (CytB), cytochrome c oxidase subunit 1 
(Cox1) and subunit 2 (Cox2) in C2C12. Additionally, the hormone induced the 
expression of the nuclear respiratory factors 1 and 2 (Nrf-1 and Nrf-2), the 
mitochondrial transcription factors A (Tfam) and B2 (TFB2M), and the optic atrophy 1 
(OPA1). The simultaneous treatment with testosterone and the androgen receptor 
antagonist, Flutamide, reduced these effects. H2O2-oxidative stress induced treatment, 
significantly decreased mitochondrial gene expression. Computational analysis 
revealed that mitochondrial DNA contains specific sequences, which the androgen 
receptor could recognize and bind, probably taking place a direct regulation of 
mitochondrial transcription by the receptor. These findings indicate that androgen 
plays an important role in the regulation of mitochondrial transcription and biogenesis 
in skeletal muscle. 
 






Testosterone is a key determinant of body composition in male mammals, 
including human, owing to its effects on muscle and fat mass. The age-related 
decrease in the levels of serum testosterone in men has been related to the loss of 
skeletal muscle mass and strength, and the physical performance [Kovacheva 2009; 
Ferrando 2002; Seidman 2007; Krasnoff 2010], also known as sarcopenia [Cruz-Jentoft 
et al. 2010]. Testosterone induces the increment in muscle size, related to hypertrophy 
of muscle fibers and significant increases in myonuclear and satellite cell numbers 
[Sinha-Hikim et al. 2002, 2003, 2006]. Existing evidence further proposes that 
exogenous testosterone supplementation results in a faster recovery from hind limb 
paralysis after injury of sciatic nerve of rat [Brown et al. 1999], and completely 
prevents apoptosis induced by castration in levator ani muscle cells in rats 
[Boissonneault et al. 2001]. Although the exact mechanisms underlying the loss of 
muscle associated with aging are far from being completely clarified, accumulating 
evidence postulates that an age-related acceleration of muscle cells loss via apoptosis 
could represent a crucial mechanism responsible for impairment of muscle 
performance [Dirks & Leeuwenburgh 2002, Dupont-Versteegden 2005]. Of relevance, 
in our laboratory we demonstrated that testosterone protects against H2O2-induced 
apoptosis in the C2C12 muscle cell line at morphological, physiological and biochemical 
level [Pronsato et al. 2010, 2012, 2016], having the androgen receptor (AR) an active 
participation in these events. C2C12 myoblasts bear resemblance to the activated 
satellite cells that surround the mature myofibers and proliferate and differentiate, 
taking part of the repair of the tissue when a cellular injury exists [Yoshida et al. 1998] 
having an vital role in skeletal muscle recovery [La Colla et al. 2015].  
The AR, a member of the superfamily of nuclear receptors which comprises a 
large group of ligand-regulated transcription factors [Katzenellenbogen and 
Katzenellenbogen 1996], mediates several biological actions of androgens. When AR 
binds to androgen, the hormone-receptor complex translocates to the nucleus, where 
the modulation of gene target expression takes place over a period of hours [He et al. 
1999; Heinlein and Chang 2002; Wierman 2007].  
Scientific evidence accumulated in the last years, suggests the existence of 
membrane androgen receptors (mAR) triggering rapid non-genomic actions, in various 
cell types such as macrophages and T cells [Benten et al. 1999a; 1999b], LNCaP [Wang 
et al. 2008], MCF7 [Kallergi et al. 2007], DU145 [Hatzoglou et al. 2005; Papadopoulou 
et al. 2008; 2009], C6 [Gatson et al. 2006], PC12 [Alexaki et al. 2006] and VSMC cells 
[Somjen et al. 2004]. Of relevance, extranuclear organelles have been also proposed as 
containing the AR. The presence of the AR in mitochondria of mammalian cells 
including skeletal muscle has been reported [Solakidi et al. 2005; Pronsato et al. 2013]. 
Biochemical and immunological data provided by our laboratory has supported the 
non-classical localization of the AR in mitochondria and microsomes of C2C12 skeletal 
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muscle cells [Pronsato et al. 2013], from where it could be participating in the 
antiapoptotic effect of testosterone on skeletal muscle [Pronsato et al. 2012]. Thus, 
non-classical localization of AR from where it can exert non-genomic actions could be 
possible.  
In skeletal muscle, mitochondrial oxidative phosphorylation serve as a major 
source of energy to meet basic metabolic needs and energy demands during physical 
activity. Some studies have linked the progressive decline in skeletal mitochondrial 
function with aging and functional decline, where physical strength declines out of 
proportion to the loss of muscle mass [Carter et al. 2012; Parise & De Lisio 2010]. To 
optimize energy production and minimize oxidative damage, mitochondria are 
engaged in dynamic network exchange through fission and fusion [Bereiter-Hahn & 
Voth 1994; Schafer & Reichert 2009]. Impairments of these mechanisms of 
mitochondrial quality control during aging contribute to the age-related increase in 
tissue oxidative damage and functional decline [Weber & Reichert 2010; Green et al. 
2011; Xu et al. 2010; Hofer et al. 2010]. Aging can be precipitately induced by oxidative 
stress, through the accumulation of reactive oxygen species (ROS) [Renault et al. 
2002]. Indeed, aging is related to excessive ROS levels, which provoke an increment in 
mitochondrial damage [Vasconsuelo et al. 2013]. Mitochondria could produce higher 
ROS levels in the aged muscle, inactivating satellite cells and thus, contributing thus to 
the impairment of its restorative function. Deficits in mitochondrial content and 
quality are often observed in aging muscle, although this topic remains under 
considerable debate [Carter et al. 2015; Hepple 2014]. Whereas some studies have 
noted no changes in mitochondria with aging, others have well documented 
reductions in mitochondrial content [Chabi et al.  2008; Ljubicic and Hood 2009], 
enhanced ROS emission [Ljubicic et al. 2009], increased apoptotic susceptibility 
[Gouspillou 2014; Chabi 2008], decreased capacity of calcium retention [Gouspillou et 
al. 2014], and an impaired signaling for biogenesis [Ljubicic and Hood 2009; Reznick et 
al. 2007]. Although mitochondrial dysfunction is thought to be associated to aging, 
how exactly aging influences mitochondrial dysfunction is not well understood.  
Mitochondrial biogenesis is an intricate event that involves both mitochondrial 
proliferation (mitochondrial mass increment) and differentiation (mitochondrial 
capacities improvement) [Attardi and Schatz 1988], whose modulation needs the 
coordinated contribution of proteins derived from both nuclear and mitochondrial 
genomes [Fernandez-Silva et al. 2003]. The mitochondrial genome (16 Kb circular 
mtDNA) encode some of the subunits of complexes I, III, IV and V of the mitochondrial 
respiratory chain (MRC) in addition to other proteins, ribosomal and transfer RNAs, 
involved in mitochondrial activity [Montoya et al. 2006]. Furthermore, mtDNA contains 
response elements for class I and II receptors, where the AR belongs to [Demonacos et 
al. 1995, 1996]. In fact, there are evidences that have taken into account that 
androgens, through the AR, can not only regulate the expression of nuclear genes that 
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encode for some subunits of the MRC, but also regulate the expression of 
mitochondrial genes that also encode for subunits of this chain. This could be through 
a direct way, by binding to the response elements for androgens present in the mtDNA 
or through an indirect way by regulating the expression of the nuclear genes that 
encode nuclear or mitochondrial transcription factors involved in the regulation of the 
expression of these subunits [Psarra et al. 2006; Usui et al. 2014]. The mode by which 
androgens mediate these events are currently unknown. Studies have assigned the 
nuclear respiratory factor-1 (NRF-1) transcription factor a key role in the integration of 
the transcription of nuclear- and mitochondrial-encoded genes [Evans and Scarpulla 
1989]. NRF-1 homodimerizes and binds to palindromic NRF-1 sites in the promoters of 
nuclear-encoded mitochondrial genes [Virbasius et al. 1993]. Target genes of NRF-1 
comprise subunits of the five MRC complexes, assembly factors for the respiratory 
apparatus, parts of the machinery needed for the mtDNA transcription and replication, 
components of mitochondrial protein import, mitochondrial and cytosolic enzymes of 
heme biosynthesis, and three crucial mtDNA transcription factors: mitochondrial 
transcription factor A (Tfam) and mitochondrial transcription factor B types 1 and 2 
(TFB1M and TFB2M) [Kelly 2004]. TFAM, TFB1M and TFB2M transcribe the 
mitochondrial genome, leading to an increment in mitochondrial-encoded subunits of 
the MRC [Kelly and Scarpulla 2004]. NRF-1 plays thus, a relevant role in the integration 
of the nucleus-mitochondria interactions [Scarpulla 2002]. On the other hand, the 
nuclear respiratory factor 2 (NRF-2) also known as GA-binding protein or GABP, has 
also been implicated in mitochondrial gene regulation and mitochondrial biogenesis. 
NRF-2 is a multi-subunit nuclear transcription factor. It belongs to the E26 
transformation-specific (Ets) family of proteins that binds the GGAA core DNA 
sequence. NRF-2 functions as a heterotetramer of two alpha subunits (NRF-2α) and 
two beta subunits (NRF-2β)—a unique property among Ets transcription factors. NRF-
2α contains the Ets DNA binding domain, whereas NRF-2β contains the transactivating 
domain and the nuclear localizing signal. Both NRF-2 subunits are expressed widely 
throughout the body [Rosmarin et al. 2004]. GABPA is a unique gene in the human and 
murine genomes [Luo et al. 1999], and GABPα is the only protein that can recruit 
GABPβ to DNA to form the transcriptionally active complex. GABP regulates lineage-
restricted myeloid and lymphoid genes that are required for innate immunity 
[Rosmarin et al. 2004], is required for cell cycle control in fibroblasts [Yang et al. 2007], 
and has been implicated in the regulation of more than one dozen mitochondrial 
genes [Ongwijitwat et al. 2005], being required for mitochondrial biogenesis [Yang et 
al. 2014]. Therefore, NRF-2 additionally works in concert with NRF-1 to integrate the 
nucleus-mitochondria transcription gene network and modulate mitochondrial 
biogenesis.  
Coordinate expression of mitochondrial- and nuclear-encoded genes has been 
suggested to be mediated by hormone receptors within mitochondria stimulating the 
expression of mtDNA-encoded genes [Chen and Yager 2004]. Given that we have 
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previously reported the non-classical localization of AR in mitochondria of skeletal 
muscle cells from where the receptor could be mediating the antiapoptotic effects of 
testosterone, a goal in the present study was to elucidate one of the pathways that may 
contribute to the observed testosterone-induced mitochondrial preservation and protection, 
by the regulation of the expression of nuclear and mitochondrial genes that 
coordinately preserve the mitochondrial integrity and functionality. Thus, this effect of 
testosterone at mitochondrial level could be part of its protective action against H2O2-
induced apoptosis in C2C12 cells. Here we tested the hypothesis that testosterone 
increases mitochondrial activity and mtDNA-encoded mRNA expression through AR-
mediated up-regulation of Nrf-1 gene transcription. We report that Nrf-1 mRNA is up-
regulated by testosterone, being this transcriptional effect mediated by AR in skeletal 
muscle cells. As consequence, NRF-1/TFAM/TFB2M/mitochondrial gene axis is 
activated, and testosterone ends up-regulating the mtDNA-encoded genes. In addition, 
the possibility that testosterone could directly influence mitochondrial oxidative 
phosphorylation gene transcription by way of cognate receptors present in 
mitochondria, has also been proposed. We computational tested the hypothesis of a 
direct regulation of mitochondrial genes by the AR. We reported several putative AR 
binding sequences in the mtDNA that could be mitochondrial androgen response 
elements, acting as enhancers of the mitochondrial encoded genes. 
 
Materials and Methods 
Materials 
Testosterone was purchased from Sigma–Aldrich. Anti-NRF-1, anti-OPA1, and 
anti-TFB2M antibodies were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). 
Alexa Fluor 488-conjugated anti-mouse secondary antibody was purchased from 
Thermo Fisher Scientific (Rockford, IL, USA). High Pure RNA Isolation kit (11828665001) 
was from Roche Diagnostics (Mannheim, Germany). High Capacity cDNA Reverse 
Transcription Kit (4368814) and SYBR® Select Master Mix were purchased from Applied 
Biosystems, and primer sets were from Invitrogen (Carlsbad, CA, USA). All other 
reagents used were of analytical grade.  
 
Cell culture and treatment 
C2C12 murine skeletal muscle cells, from the American Type Culture Collection 
(ATCC number: CRL-1772TM) at Manassas, VA 20108, were cultured in growth medium 
(Dulbecco’s modified Eagle’s medium) supplemented with 10% heat-inactivated (30 
min, 56 °C) fetal bovine serum, 1% nystatin, and 2% streptomycin. Cells were 
incubated at 37 °C in a humid atmosphere of 5% CO2 in air. Cultures were passaged 
every 2 days with fresh medium. Under these conditions, C2C12 myoblasts resemble 
the activated satellite cells that surround the mature myofibers and proliferate and 
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differentiate, participating in the repair of the tissue when a cellular injury exists 
[Yoshida et al. 1998]. Cells were cultured in chamber slides for microscopy or in 10 cm 
plates (Greiner Bio-One, Frickenhausen, Germany) for Western blots. The treatments 
were performed with 70-80% confluent cultures (120,000 cells/cm
2
) in medium 
without serum for 30 min or during the longest treatment time that the experiment 
takes and this will be named Control condition. Then, treatments were carried out by 
adding 10
-9
 M testosterone at physiological concentration [Pronsato et al. 2010, 2012; 
Kerry et al. 2004] or the hormone vehicle, isopropanol (IPA) (the IPA percentage in the 
culture medium assay, of cells treated with the hormone or the hormone vehicle 
alone, was less than 0.001%) during the times indicated for each experiment. For AR 
evaluation, cells were treated with 10
-8
 M Flutamide for 60 min and then expose to 10
-
9
 M testosterone during the time specified for each experiment. The induction of 
apoptosis with H2O2 was evaluated during the periods of time indicated for each 
experiment, by the dilution of H2O2 in culture medium without serum at a final 
concentration of 1 mM. To obtain a total cell lysate, a buffer composed of 50 mM Tris-
HCl pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.2 mM Na2VO4, 25 mM NaF, 
1 mM PMSF, 20 µg/ml leupeptin, 20 µg/ml aprotinin and 20 µg/ml trypsin inhibitor, 
was employed. The lysates were collected by aspiration and centrifuged at 12,000 g 
during 5 min to separate the particulate fraction from the soluble fraction. Protein 
concentration from the supernatant was estimated by the method of Bradford 
[Bradford 1976], using bovine serum albumin (BSA) as standard.  
 
Western blot analysis 
Protein aliquots (25 mg) were combined with sample buffer (400 mM Tris-HCl 
(pH 6.8), 10% SDS, 50% glycerol, 500 mM dithiothreitol (DTT), and 2 mg/ml 
Bromophenol Blue, boiled for 5 min and resolved by 10% SDS-PAGE. Fractionated 
proteins were then electrophoretically transferred onto PVDF membranes (Immobilon-
P; Millipore, Darmstadt, Germany), using a semi-dry system. Nonspecific sites were 
blocked with 5% nonfat dry milk in PBS containing 0.1% Tween-20 (PBS–T). Blots were 
incubated overnight with the appropriate dilution of the primary antibodies. The 
membranes were repeatedly washed with PBS–T prior incubation with horseradish 
peroxidase-conjugated secondary antibodies. The enhanced chemiluminescence (ECL) 
blot detection kit (Amersham, Buckinghamshire, England) was used as described by 
the manufacturer to visualize reactive products. For tubulin loading control, 
membranes were stripped with stripping buffer (62.5 mM Tris-HCl, pH 6.7; 2% SDS; 50 
mM β-mercaptoethanol), washed with PBS 1% Tween-20 and then blocked for 1 h with 
5% nonfat dry milk in PBS containing 0.1% Tween-20 (PBS–T). The blots were then 
incubated for 1 h with the antibody. After several washings with PBS-T, membranes 
were incubated with the secondary conjugated antibody. The corresponding 
immunoreactive bands were developed by means of ECL. Relative quantification of 
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After treatments, semi-confluent (60-70%) monolayers were washed with 
serum-free phenol red-free DMEM, and then fixed and permeabilized during 20 min at 
-20 °C with methanol to allow intracellular antigen labeling. After fixation, cells were 
rinsed 3 times with PBS. Non-specific sites were blocked for 30 min in PBS that 
contained 5% bovine serum albumin. Cells were then incubated overnight at 4 °C, in 
the presence or absence (negative control) of primary antibodies (1:50 dilution). The 
primary antibodies were recognized by fluorophore-conjugated secondary antibodies. 
Finally, the coverslips were analyzed by conventional fluorescence microscopy. 
 
Quantitative Real Time RT-PCR 
C2C12 cells were treated during different periods of time with 1 mM H2O2 or 
with 10−
9
 M testosterone or preincubated with Flutamide 10
-8
 M and then expose to 
10−
9
 M testosterone for the times specified. After treatments, total RNA (10−
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cells/condition) was extracted using the High Pure RNA Isolation kit (Roche 
Diagnostics, Mannheim, Germany) and approximately 2 μg of total RNA was reverse 
transcribed with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems 
Inc., CA, USA) according to the manufacturer´s instructions. The RNA and cDNA 
purity has been checked by the measurement of 260/280 nm ratio.  Quantitative 
measurement of real-time PCR was done using SYBR® Select Master Mix under the 
standard conditions recommended by the manufacturer. Primer sets to amplify murine 
cDNAs used in the analysis were as follows: glycelaldehyde 3-phosphate 
dehydrogenase (Gapdh) set: forward 5´CGTCCCGTAGACAAAATGGT3´, reverse 
5´TTGATGGCAACAATCTCCAC3´; mitochondrial transcription factors A (Tfam) set: 
forward 5´CCCCTCGTCTATCAGTCTTGT3´, reverse 5´ CTGCTTCTGGTAGCTCCCTC 3´;  
nuclear respiratory factors 1 (Nrf-1) set: forward 5´ TCTCACCCTCCAAACCCAAC 3´, 
reverse 5´CCCGACCTGTGGAATACTTG3´; GA binding protein alpha (Gabpa) also 
named as nuclear respiratory factors 2 (Nrf-2) set: forward  5´ 
CCGGGGAACAGAACAGGAAA 3´, reverse  5´ ACGTTGTCCCCATTTTTGCG 3´; NADPH 
dehydrogenase subunit 1 (ND1) set: forward 5´CAACCATTTGCAGACGCCAT3´, reverse 
5´TTGGGCTACGGCTCGTAAAG3´, NADPH dehydrogenase subunit 4 (ND4) set: forward 
5´CTCCTCAGACCCCCTATCCA3´, reverse 5´AAATCCCTGCGTTTAGGCGT3´; cytochrome c 
oxidase subunit 1 (Cox1) set: forward 5´TGCAACCCTACACGGAGGTA3´, reverse 
5´GTGGGCTTTTGCTCATGTGT3´; cytochrome c oxidase subunit 2 (Cox2) set: forward 
5´TTGCTCTCCCCTCTCTACGC3´, reverse 5´TCTATTGGCAGAACGACTCGG3´; cytochrome b 
9 
 
(CytB) set: forward 5´GCCCTAGCAATCGTTCACCT3´, reverse 
5´ATGGGGTGGGGTGTTTAGTG3´. The specificity of PCR products was confirmed by 
melting curve analysis. Relative quantification of gene expression was determined by 
the comparative CT method [Giulietti et al. 2001; Livak and Schmittgen 2001].  
 
AR motif analysis 
Putative transcription factor binding sites (TFBS) of the AR were computational 
predicted and scanned within the murine mitochondrion genome utilizing a position-
weight matrix (PWM) scan as implemented in PWMScan 
(https://ccg.epfl.ch/pwmtools/pwmscan.php) and described by Ambrosini and 
coworkers [Ambrosini et al. 2018]. Available mouse mitochondrion complete genome 
sequence (RefSeq: NC_005089.1) was extracted from NCBI Entrez gene database 
[Maglott et al. 2005]. PWMs were taken from the open access database JASPAR [Khan 
et al. 2018], HOCOMOCO [Kulakovskiy et al. 2018] and CIS-BP [Weirauch et al. 2014], 
which provide PWMs derived not only from SELEX experiments and individual 
promoter assays, but also from ChIP-Seq data using MEME for motif discovery [Bailey 
et al. 2009]. The P-value of a PWM score x is defined as the probability that a random k-mer 
sequence of the length of the PWM has a binding scorex given the base composition of the 
genome [Ambrosini et al. 2018]. A stringent p-value cut-off less than 1x10
-5
, that is 
recommended by developers of the PWMScan website [Ambrosini et al. 2018] has been 
employed. Only motifs with scores > 1000 for 10-15 bp sequences were selected. Each 
motif was lined to mouse mitochondrial genome by the employment of BLASTn with 
100% homology.  
 
Statistical analysis 
Results are shown as means ± standard deviation (S.D.) Statistical differences 
among groups were determined by one-way analysis of variance (ANOVA) followed by 
the Fisher´s Least Significant Difference (LSD) test, a multiple comparison post hoc test. 




Testosterone regulates nuclear and mitochondrial transcription factors gene 
expression in C2C12 muscle cells  
NRF-1 and NRF-2 (also known as GA-binding protein or GABP), are primary 
transcription factors of nucleic DNA encoded mitochondrial proteins [Wu et al. 1999]. 
NRF-1 and NRF-2 in turn modulate the gene expression of mitochondrial transcription 
factors A (TFAM), B1 (TFB1M), and B2 (TFB2M), which are indispensable for the 
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activation of mitochondrial DNA transcription [Chen et al. 2009]. Thus, they play a key 
role in the integration of the transcription of nuclear- and mitochondrial-encoded 
genes. In order to evaluate if testosterone regulates the expression of the transcription 
factors that are responsible for the proper expression of the MRC proteins and thus, 
the correct mitochondrial functioning, the expression of Nrf-1, Nrf-2 and Tfam genes 
were analyzed by quantitative PCR. Their relative levels were determined by the 
employment of the comparative CT method described in Methods. C2C12 cell cultures 
were treated with 10−
9 
M testosterone during different periods of time, ranging 
between 30 min and 4 h, or pretreated with Flutamide 10
-8
 M for 60 min, and then 
expose to 10−
9 
M testosterone for the same times mentioned above. The mRNA was 
then isolated and the relative expression levels of the genes were quantified. The 
Gapdh was used as a reference gene.  
In C2C12 cells, testosterone induced the upregulation of Nrf-1 and Nrf-2 genes, 
in a time dependent way, with a maximum expression at 30 min of testosterone 
treatment. From then on, the expression of Nrf-1 and Nrf-2 decreased gradually, 
reaching control levels after 4 h of treatment. Of relevance, the employment of the 
antagonist of AR, Flutamide, reduced testosterone effect, suggesting the participation 
of the AR in the positive modulation of these transcription factors (Figure 1). Similar 
results were obtained when the expression of NRF-1 protein was analyzed by Western 
blot assay and immunocytochemistry. C2C12 cultures were incubated with the 
hormone 10
-9
 M during the periods of time specified. In order to evaluate if the AR was 
mediating the effect of the hormone in this event, cells were treated in addition with 
flutamide (10
-8
 M, 60 min) prior to testosterone. Then, immunocytochemical detection 
of NRF-1 was performed on C2C12 cultures by fluorescence microscopy, or total 
homogenates were obtained and analyzed by Western blot assay.  Testosterone was 
able to enhance NRF-1 expression over control in a time-dependent way, with a 
maximum of expression at 1h 30min. From then on, NRF-1 slightly decays. 
Pretreatment with Flutamide, almost completely blocks testosterone effect (Figure 
2A). The employment of conventional microscopy and immunocytochemistry allowed 
us to observe besides, the nuclear localization of the transcription factor after 
testosterone treatment, where it exerts its function at transcriptional level. This effect 
was reduced by Flutamide (Figure 2B), that leads to NRF-1 permanence in cytosol and 
to clean nucleus.    
Testosterone upregulated Tfam gene expression as well, after 4 h treatment, 
effect that was reduced by Flutamide pretreatment (Figure 1). 
 
 
Testosterone induces the TFB2M expression that oxidative stress downregulates  
 
As it was mentioned, TFAM is essential for the activation of mtDNA transcription, 
and TFB1M and TFB2M, acting as auxiliary factors for promoter recognition, are 
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necessary for basal transcription of mtDNA. With the aim of study the effect of the 
apoptotic agent on the transcription factor TFB2M in C2C12 cells, cultures were 
exposed to 1 mM H2O2 during different periods of time ranging from minutes to hours 
(15 and 30 min, 1, 2, 3, 4 and 6 h). Using a specific antibody against TFB2M, Western 
blot assay showed that H2O2 significantly reduced TFB2M expression respect to the 
Control, in a time-dependent way from 30 min of treatment (Figure 3A). On the other 
hand, when cells were treated with testosterone 10
-9
 M during different times (10 and 
30 min, 2, 4 and 20 h), TFB2M enhanced its expression over control levels (cells treated 
with the vehicle of the hormone) from 30 minutes of testosterone treatment (Figure 
3B). These results show a protective effect against H2O2-induced apoptosis that the 
hormone could be exerting by preserving the correct transcription of mtDNA. 
 
 
H2O2-induced oxidative stress downregulates mitochondrial genes that encode 
MRC proteins in C2C12 muscle cells 
 
MRC is one of the most important structural and functional parts of 
mitochondria. It consists of a series complexes of metalloproteins bound to the 
mitochondrial inner membrane that cooperate in electron transfer and proton 
pumping across the inner mitochondrial membrane. The better-known function of 
MRC is its ability to produce the majority (more than 90%) of cellular energy as ATP 
form, generating a large quantity of ROS as well. ROS play a significant role in redox 
regulation of gene expression, the control of cell proliferation and apoptosis, as well as 
serving as second messenger involved in the modulation many physiological and 
pathological activities. ROS also have the potential of causing oxidative damage to DNA 
and other critical molecules within the mitochondria. Mitochondrial dysfunction, such 
as reductions in protein and mRNA levels of the mitochondrial respiratory chain, is 
believed to be involved in aging and age-related skeletal muscle diseases, such as 
sarcopenia [Boengler et al. 2017; Peterson et al. 2012]. 
In order to evaluate the mitochondrial gene expression during H2O2-induced 
apoptosis in C2C12 cells, we analyzed by quantitative PCR, the relative levels of some 
mitochondrial DNA encoded proteins of the MRC, such as ND1 and ND4, cytochrome b 
and COX1 and COX2, which are components of complexes I, III, and IV, respectively. 
For this purpose, we employed the comparative CT method described in the Materials 
and Methods section. Total RNA from cell cultures exposed to 1 mM H2O2 during 
different times, ranging between 30 min and 4 h, was isolated and employed to 
determine the relative levels of mRNA expression. The mRNA was then isolated and 
the relative expression levels were quantified. The Gapdh gene was used as a 
reference.  
In C2C12 cells, H2O2 provoked the downregulation of Cox1, Cox2, ND1, ND4 and 
CytB gene expression, reaching their lower levels after 3-4 h of treatment. These 
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results suggest that oxidative stress induced by H2O2 contributes to mitochondrial 
dysfunction by reducing the proteins that conform the MRC and thus altering the most 
important structural and functional parts of mitochondria (Figure 4). 
 
 
Testosterone upregulates mitochondrial genes that encode MRC proteins in 
C2C12 muscle cells  
 
NRF-1 stimulates transcription of the mitochondrial transcription factor TFAM by 
binding to an Nrf-1 response element in the Tfam promoter [Virbasius et al. 1994]. 
Consequently, TFAM increases the transcription of mtDNA-encoded gene targets 
[Scarpulla 2002]. Given our previous results showing testosterone-induced increase of 
Nrf-1 and Tfam transcription factors, we investigate then if it leads to the induction of 
the downstream stimulation of the transcription mitochondrial-encoded Tfam target 
genes. Thus, the expression of the mitochondrial-encoded mRNAs, Cox1, Cox2, ND1, 
ND4 and CytB were analyzed by quantitative PCR using the comparative CT method 
described in Methods. Cell cultures were treated with 10−
9 
M testosterone during 
different periods of time ranging between 30 min and 4 h, or pretreated with 
Flutamide 10
-8
 M for 60 min, and then expose to 10−
9 
M testosterone for the same 
times mentioned above. The mRNA was then isolated and the relative expression 
levels of the genes were quantified. Gapdh gene was used as a reference.  
In C2C12 cells, testosterone induced the upregulation of the mitochondrial genes 
that encode the MRC proteins, in a time dependent way, with a peak of expression at 4 
h of testosterone treatment for Cox1, Cox2, ND4 and CytB, and a maximum expression 
from 1h to 4h of hormone treatment for ND1. Of relevance, pretreatment with 
Flutamide, almost totally abolish testosterone effect, pointing to the participation of 
the AR in the positive modulation of these mitochondrial genes (Figure 5). These 
results strongly suggest that testosterone indirectly regulates mitochondrial gene 




Testosterone promotes mitochondria preservation by the induction of the 
expression of OPA1 in C2C12 cells 
 
OPA1 (optic atrophy protein 1) is a nuclear-encoded mitochondrial protein with 
similarity to dynamin-related GTPases, that helps to regulate mitochondrial stability 
and energy output. It is a widely expressed protein localized in the inner mitochondrial 
membrane, where it forms a diffusion barrier for proteins stored in mitochondrial 
cristae. It regulates mitochondrial fusion and cristae morphology and protects against 
apoptosis [Frezza et al. 2006; Olichon et al. 2003; Griparic et al. 2004]. Intrinsic 
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apoptotic signals mediated proteolytic processing leads OPA1 oligomers disassembly 
and caspase activator cytochrome C release into mitochondrial intermembrane spaces. 
In order to evaluate the effect of testosterone on this key mitochondrial protein, 
C2C12 cells were treated with testosterone 10
-9
 M during different times (30 min, 1, 2, 
4 and 6 h) to compare them to those treated with the vehicle of the hormone (IPA 
0.001%) or maintained in DMEM (C). Western blot assay employing a specific antibody 
against OPA1 revealed that testosterone was able to increase OPA1 expression in a 
time dependent way, being its highest level after 6h treatment (Figure 6). This result 
supports the idea of the protective effect of testosterone against apoptosis at 
mitochondrial level, in skeletal muscle. 
 
 
Prediction of the putative transcription factor binding sites (TFBSs) of AR in 
murine mitochondrial genome 
 
Knowing where transcription factors (TFs) bind to the genome is the key to 
understanding gene regulation [Narlikar and Ovcharenko 2009]. The prediction of 
TFBSs is a big challenge for computational biologists, mainly as increasing amounts of 
sequence data become available. Prediction of TFBSs is usually performed by scanning 
a DNA sequence of interest with a position weight matrix (PWM) for a TF of interest 
[Hannenhalli 2008; Garcia-Alcalde et al. 2010] and many pattern-matching tools have 
been developed for this purpose. A PWM comprises weights for each base at each 
motif position. By summing up weights at corresponding positions, a binding score can 
be computed for any base sequence of the same length as the PWM. Thus, PWMs 
became an essential computational tool and model of choice to describe sequence 
binding specificities of particular TF-DNA interactions. Large collections of TF specificity 
matrices are currently available from public libraries such as JASPAR [Khan et al. 2018], 
CIS-BP [Weirauch et al. 2014], or HOCOMOCO [Kulakovskiy et al. 2018]. 
 In order to identify if the mouse mitochondrial genome contains sequence-
specific binding sites for the AR, from which it could be mediating a direct 
transcriptional regulation of mitochondrial genes, we performed an in silico genome 
analysis. The PWMs of AR were used to scan all the mouse mitochondrial genome, 
obtained in FASTA format from NCBI (RefSeq: NC_005089), for putative AR-binding 
sites, by the employment of the PWMScan tools [Ambrosini et al. 2018]. The search led 
to the identification of several putative TFBSs with p-value < 0.0001 and matches 
scores over 1000, located at various sites of the mitochondrial genome (Table 1). Two 
sequences located in the regulatory site of the genome, the D-loop region, and the 
others within the ribosomal subunit genes 12S RNA and 16S RNA, the tRNA-Leu and 
tRNA-Val and within the structural genes ND1 and Cox1 (Figure 7). Besides, some 
putative TFBSs have been also detected in the complementary light chain (Table 1), 
one of them within ND6 gene. The AR matrix obtained from JASPAR do not reveal any 
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specific AR binding sequence with cut off score 1000. Of relevance, all putative TFBSs 
obtained were aligned with mouse mitochondrion complete genome by the 
employment of BLASTn, obtaining 100% homology between the queries and a site in 
the genome (data not shown), confirming the presence of these sequence-specific 
binding sites for the AR in mtDNA. These results show the presence of sequence inside 
the mitochondrial genome, that the AR could recognize, bind and exert its function as 
transcription factor by modulating mitochondrial gene transcription.   
 
Discussion 
Numerous in vitro and in vivo studies demonstrate that the androgen-AR 
signaling pathway is necessary for skeletal muscle development and for sustaining 
muscle mass, strength and protein synthesis [Herbst et al. 2004]. We have formerly 
reported that testosterone protects skeletal muscle C2C12 cells against apoptosis 
through a mechanism involving intermediates of the apoptotic intrinsic pathway and 
the AR [Pronsato et al. 2012]. It is well known that mitochondria play a key role in 
apoptosis triggered by many stimuli [Herynk et al. 2004]. Of significance to our work, 
the presence of steroid hormone receptors in this organelle has been demonstrated in 
a range of cells [Monje et al. 2001; Cammarata et al. 2004; Chen et al. 2004; Yang et al. 
2004; Milanesi et al. 2008, 2009; Solakidi et al. 2005]. Indeed, our previous work, have 
demonstrated the presence of functional androgen binding sites in mitochondria 
[Pronsato et al. 2013]. The biochemical and immunological similarity between the 
reactive entities detected in mitochondria with the AR allow us to propose the 
presence of extranuclear AR in the C2C12 murine myoblast cell line. In this work, we 
demonstrate that testosterone through its receptor regulates mitochondrial 
respiratory chain biogenesis via the NRF/TFAM/TFB2M-mitochondria axis, in skeletal 
muscle cells. Testosterone prevents mitochondrial dysfunction strengthen thus, its 
antiapoptotic effect at mitochondrial level, probably directly mediating its function the 
non-classical mitochondrial AR. 
With advancing age, mitochondria are often reported to diminish in volume and 
function within skeletal muscle. The mechanisms responsible for age-related 
mitochondrial loss are not fully understood and continue to be elucidated. To produce 
fully functioning, high-quality organelles, coordination between the nuclear and 
mitochondrial genomes is necessary to produce protein products in the correct 
stoichiometry. The biogenesis of mitochondria needs the expression of several genes 
encoded by both nuclear and mitochondrial genomes [Garesse and Vallejo 2001]. 
However, since the protein coding capacity of mtDNA is limited to 13 respiratory 
subunits, nuclear genes must provide the vast majority of products required for 
mitochondrial oxidative functions and biosynthetic capacity. Additionally, nuclear 
genes must play a major role in controlling mitochondrial transcription, translation, 
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and DNA replication. The NRF transcription factor has been suggested to play a key 
role in the integration of the transcription of nuclear- and mitochondrial-encoded 
genes [Evans 1989]. It is activated by the peroxisome proliferator activated receptor 
gamma coactivator 1 alpha (PGC-1α), the master regulator of mitochondrial 
biogenesis. NRF-1 and NRF-2, act on the majority of nuclear genes encoding subunits 
of the respiratory complexes. They are also involved in the expression of mitochondrial 
transcription and replication factors, such as TFAM, involved in the regulation of the 
transcription and replication of the mitochondrial genome [Clayton 1992, Dairaghi et 
al. 1995, Puigserver and Spiegelman 2003], heme biosynthetic enzymes, and other 
proteins essential for respiratory function. TFB1M and TFB2M are also subject to NRF-1 
and NRF-2 regulation, suggesting that these factors could be involved in the 
integration of the expression of respiratory subunits with components of the 
mitochondrial transcriptional machinery [Virbasius and Scarpulla 1994]. Regulation of 
these transcription factors and thus, the modulation of the mitochondrial genome by 
estrogens, have been well reported, being its receptor, a key modulator of these 
events [Chen et al. 2009; Mattingly et al. 2008]. However, little is known about the 
effects of androgens on the regulation of the expression of these factors and the 
proteins regulated by them. In this work, we demonstrate that testosterone at 
physiological concentration induce the expression of Nrf-1 and Nrf-2, effect that leads 
to an increased expression of not only Tfam, but also, TFB2M, in skeletal muscle cells. 
Of relevance, these events are reverted in the presence of the AR antagonist, 
Flutamide. Because testosterone induces the expression of Tfam, and possibly TFB2M 
via activation of NRF-1 and NRF-2, it is likely that T and AR stimulate the mtDNA 
transcription via induction of these mitochondrial transcription factors expressions. 
Accordingly, considering that TFAM and TFBs transcribe the mitochondrial genome, 
testosterone treatment resulted in an increase of mRNA transcription levels of mtDNA-
encoded protein subunits that comprising the mitochondrial respiratory chain. mRNA 
expression of the subunits of complex I, III and IV of MRC, ND1, ND4, CytB, Cox1 and 
Cox2 were increased after testosterone treatment. The employment of Flutamide was 
able to almost totally inhibit the effect of the hormone, showing the requirement of 
the AR for the modulation of these effects. These findings suggest that testosterone 
exerts a relevant role in the modulation of mitochondrial gene expression in skeletal 
muscle. Consistent with our observations in skeletal muscle, others reported an 
important role of AR in maintaining oocyte quality and fertility by controlling the 
signals of PGC1α-mediated mitochondrial biogenesis in granulosa cells [Wang et al. 
2015]. Testosterone deficiency in brain causes an important reduction in mtDNA gene 
expression namely ND1, ND4, cytochrome b, and Cox1 and Cox3, in the hippocampus, 
as a consequence of the downregulation of PGC-1α, its downstream transcriptional 
factors, NRF-1 and NRF-2, and mitochondrial transcription factors A and B2, assigning 
androgen an important role in mitochondrial hippocampus [Hioki et al. 2014]. With 
regard to skeletal muscle, testosterone administration in addition to low-intensity 
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physical training in mice has been associated with improvements in muscle mass, grip 
strength, spontaneous movements, and respiratory activity, being these improvements 
related to increased muscle mitochondrial biogenesis and quality [Guo et al. 2012]. 
Usui et al. firstly reported that testosterone-treated mice exhibited elevated heat 
production, associated to the activation of PGC-1α/NRF/TFAM/mitochondrial genes 
axis, deriving the increase in energy expenditure induced by testosterone, from 
elevated mitochondrial biogenesis in skeletal muscle [Usui et al. 2014]. Our results 
deepen the knowledge about the role of testosterone and its receptor in mitochondrial 
biogenesis as a key action of their protective effect against H2O2-induced apoptosis in 
C2C12 skeletal muscle cells.  
Accompanied by mitochondrial biogenesis, mitochondrial dynamics (i.e. fission 
and fusion processes) is vital for accurate mitochondrial function, and even minor 
failure in mitochondrial dynamics are related to muscle pathologies such as sarcopenia 
[Gorgey et al. 2019; Huang et al. 2019]. Mitochondria in skeletal muscle undergo 
fusion and fission in response to the state of the muscle fiber to guarantee there is 
enough capacity for energy production during demanding events. The mitochondria 
undergo fusion in skeletal muscle to generate a tightly regulated reticulum that rises 
the efficiency of oxidative phosphorylation [Glancy et al. 2015]. Mitochondrial fusion is 
regulated by the outer membrane fusion proteins mitofusion 1 and 2 (MFN 1–2) and 
inner membrane fusion protein optic atrophy 1 (OPA1). Decreases in these proteins 
are related to mitochondrial dysfunction, induction of apoptosis and muscle atrophy 
[Chen et al. 2010; Olichon et al. 2003]. We found that testosterone, which enhances 
key intermediates factors of mitochondrial biogenesis, also stimulates mitochondrial 
fusion by upregulating OPA1 expression. Thus, testosterone helps to maintain 
balanced mitochondrial dynamics in skeletal muscle, ensuring a proper mitochondrial 
and, therefore, cell function. 
H2O2 has been demonstrated to be a signaling molecule implicated in many 
cellular functions such as apoptosis [Singh & Singh 2008; Vasconsuelo et al. 2008], 
differentiation [Steinbeck et al. 1998; Orzechowski et al. 2002], and proliferation 
[Sigaud et al. 2005]. Cell exposure to exogenous H2O2 has been used to investigate 
multiple signaling pathways related to smooth muscle contraction [Jin and Rhoades 
1997], proliferation [Baas and Berk 1995] and apoptosis [Li et al. 1997]. H2O2 induces 
apoptosis in C2C12 cells in a time-dependent manner. At short times of exposure, H2O2 
induces the activation of a cell defense response to avoid apoptosis, while at long 
treatment times, the programmed cell death finally starts. The loss of the 
mitochondrial membrane potential, the mitochondrial permeability transition pore 
(mPTP) opening and cytochrome c release take place, and it is at this time when the 
protective action of testosterone against apoptosis is evidenced [Pronsato et al. 2013, 
2016]. In this research it has been demonstrated that H2O2-induced oxidative stress 
significantly downregulates the mRNA expression of the MRC proteins ND1, ND4, CytB, 
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Cox1 and Cox2 respect to the Control in C2C12 cells. In addition, the auxiliary factor for 
promoter recognition, TFB2M was also reduced by the exposure to the apoptotic 
agent in a time dependent manner. Thus, it is probably that by the inhibition of 
NRF/TFAM/TFB2M/mitochondrial genes axis, the apoptotic agent destabilize 
mitochondrial integrity and functionality, leading finally to apoptosis of skeletal muscle 
cells. These effects were totally opposite to those obtained with physiological 
concentrations of testosterone treatment; strengthen the antiapoptotic role of the 
steroid in skeletal muscle. 
One prevailing and indirectly view of hormonal regulation of mitochondrial 
transcription is that the hormonal stimulus primarily leads to the induction of the 
activation of nuclear-encoded mitochondrial transcription factors, which secondarily 
stimulate mitochondrial RNA synthesis, after translocating to the organelle [Pillar and 
Seitz 1997]. Alternatively, transcription factors can be imported into mitochondria and 
alter transcription from the mitochondrial genome as ‘direct regulators’ of 
mitochondrial gene expression. The identification of glucocorticoid [Demonacos et al. 
1993; Scheller et al. 2000; Moutsatsou et al. 2001]  estrogen [Monje et al. 2001; 
Cammarata et al. 2004; Chen et al. 2004; Yang et al. 2004; Milanesi et al. 2008, 2009]  
and thyroid [Wrutniak et al. 1995; Casas et al. 2003] hormone receptors in 
mitochondria and the presence, in the mitochondrial genome, of nucleotide sequences 
not only with high homology to hormone-responsive elements (HRE), but also with 
high capability to bind steroid and thyroid receptors, strengthen the notion of a direct 
effect of these hormones on mitochondrial transcription [Sekeris 1990; Demonacos et 
al. 1996; Wrutniak et al. 1995; Casas et al. 1999; Enriquez et al. 1999; Chen et al. 2004; 
Psarra et al. 2006]. However, lesser is known about the androgen receptor. Although 
we have previously demonstrated the mitochondrial localization of the AR capable of 
selectively binding androgens [Pronsato et al. 2013], a critical question remains 
unknown about the functional role of the mtAR in the global antiapoptotic effects of 
testosterone in skeletal muscle. Is the localization of AR in mitochondria a mechanism 
by which the cell synchronizes the nuclear and mitochondrial transcriptional responses 
for integrated responses to androgen? Or, do the effects of testosterone on 
mitochondria have particular roles in modulating transcription of certain mitochondrial 
genes? 
To begin to elucidate this issue, we employed computational tools to look for 
specific DNA sequence, in mouse mitochondrial genome, that could act as potential 
androgen response elements (ARA) from where AR could modulate mitochondrial 
gene expression. Unlike nuclear genes, that often has multiple promoters, all 
mitochondrial genes are expressed together from only three promoters encoded in the 
regulatory D-loop region [Montoya et al. 1982], which are recognized by the 
mitochondrial basal transcriptional machinery: the mitochondrial RNA polymerase 
(Polrmt), and the mitochondrial transcription factors TFAM and TFB2M [Falkenberg et 
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al. 2007; Cotney et al. 2009]. The resulting three polycistronic transcripts do not 
undergo splicing (because of the absence of introns in the mtDNA), but are processed 
by an RNAse that remove tRNAs to release the mRNA and rRNA [Ojala et al. 1981] 
before mRNA translation in the mitochondrial matrix. In this work we have identify 
several putative AR binding sites in murine mitochondrial genome, that are present 
not only at the regulatory region (D-loop) of the mtDNA, where the promoters are 
located, but also at other sites (within structural genes and at the ribosomal RNA or 
tRNA genes). The presence of TFBSs also in sites other than the D-loop suggests 
possible effects not only in the initiation but also at other steps of the mitochondrial 
transcription process, such as transcript elongation, release and processing.  
As a conclusion, the presence of common nucleotide sequences in the nuclear 
and mitochondrial genomes to which AR could bind, suggests the possibilities of a 
coordination of transcription between the two genomes. Thus, testosterone could, by 
a direct AR–DNA interaction stimulate parallel transcription in both nucleus and 
mitochondria. Additionally, by the induction of nuclear-encoded mitochondrial 
transcription factors, the hormone could produce the same effect. Thus, AR could 
directly regulate mitochondrial transcription or indirectly lead to the same effect by 
activating NRFs/TFAM-TFB2M/mitochondrial genes axis. Our study highlights the key 
role of androgens for mitochondrial gene expression in skeletal muscle and provides 
an explanation of the antiapoptotic effect of the hormone in aged-skeletal muscle 
underlying age-related reduction in mitochondrial proteins, function and quality. These 
data in addition to our previous findings sustain the significant role of testosterone in 
the inhibition of several cellular pathways in muscle cells that acting in concert 
conduce to apoptosis. Clearly, additional studies are necessary to further characterize 
the relative role of the muscle cell mtAR in mitochondrial biogenesis and to clarify the 
signaling mechanisms that mediate the antiapoptotic action of testosterone through 
the apoptotic intrinsic pathway in skeletal muscle cells, and its relationship with 
myopathies associated with hormonal dysregulation.   
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Figure 1: Testosterone upregulates Nrf and Tfam transcription factors gene expression 
in C2C12 cells. Transcript levels of Nrf-1, Nrf-2 and Tfam were determined by Real Time 





Flutamide for 60 min and then exposed to 10
-9
 M Testosterone for 30 min (T + F 30), 1 
h (T + F 1 h), 3 h (T + F 3 h) and 4 h (T + F 4 h) or treated with 10
-9
 M Testosterone 
alone for the same periods of time; (C) Untreated cells. Transcript levels are expressed 
in arbitrary units related to the expression of Gapdh gene expression. Averages ± S.D. 
are given; * p < 0.05 respect to Control condition; # p < 0.05 respect to the counterpart 
T condition.  
 
Figure 2: Testosterone induces NRF-1 protein expression and its nuclear location in 
C2C12 cells. A) C2C12 cultures preincubated with 10
−8
 M Flutamide for 60 min and 
then exposed to 10
-9
 M Testosterone for 30 min (T + F 30), 1 h 30min (T + F 1h 30´) and 
3 h (T + F 3h) or treated with 10
-9
 M Testosterone alone for the same periods of time; 
(C) Untreated cells. Cell lysates were prepared and subjected to Western blot analysis 
using anti-NRF-1 antibody. β-Tubulin levels are shown as protein loading control. The 
bands were quantified by densitometry. B) Cells grown on coverslips were 
preincubated with 10
−8
 M Flutamide for 60 min and then exposed to 10
-9
 M 
Testosterone for 30 min (T + F 30), 1 h (T + F 1h) and 4 h (T + F 4h) or treated with 10
-9
 
M Testosterone alone for the same periods of time; (C) Untreated cells. Then cells 
were labeled with anti-NRF-1 as described in Methods. At least ten fields per slide 
were examined by fluorescence microscopy. Representative photographs are shown. 
Magnification: 63X 
 
Figure 3: Time course of H2O2 and testosterone modulation of TFB2M expression in 
muscle cells. A) C2C12 cells were incubated with 1 mM H2O2 for the indicated time 
periods or maintained in DMEM (C). Cell lysates were prepared and subjected to 
Western blot analysis using anti-TFB2M antibody. β-Tubulin levels are shown as 
protein loading control. The bands were quantified by densitometry. The blot is 
representative of three independent experiments with comparable results. Averages ± 
S.D are given. *p < 0.05 respect to the control (C). B) C2C12 cells were treated during 
the indicated periods of time with 10
-9
 M testosterone or IPA (0.001%). Western blot 
analyses were performed using anti-TFB2M antibody. β-Tubulin level is shown as 
loading control. The blots are representative of three independent experiments with 
comparable results. Densitometric quantification of the blot is shown. Averages ± S.D 
are given. *p < 0.05 respect to the counterpart IPA control condition. 
 
Figure 4: H2O2-induced oxidative stress downregulates mitochondrial gene expression 
in C2C12 cells. Transcript levels of ND1, ND4, Cox1, Cox2, and CytB were determined by 
Real Time PCR as described in Methods, using C2C12 cultures exposed to 1 mM H2O2 
for 30 min (H30), 1 h (H 1h), 3 h (H 3h) and 4 h (H 4h) or (C) untreated. mRNA levels are 
expressed in arbitrary units related to the expression of Gapdh gene. Averages ± S.D. 
are given; *p < 0.05 respect to Control condition. 
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Figure 5: Testosterone upregulates mitochondrial genes of the MRC in C2C12 cells. 
Transcript levels of ND1, ND4, Cox1, Cox2, and CytB were determined by Real Time PCR 
as described in Methods. C2C12 cultures were preincubated with 10
−8
 M Flutamide for 
60 min and then exposed to 10
-9
 M Testosterone for 30 min (T + F 30), 1 h (T + F 1 h), 3 
h (T + F 3 h) and 4 h (T + F 4 h) or treated with 10
-9
 M Testosterone alone for the same 
periods of time; (C) Untreated cells. Transcript levels are expressed in arbitrary units 
related to Gapdh gene expression. Averages ± S.D. are given; * p < 0.05 respect to 
Control condition; # p < 0.05 respect to the counterpart T condition. 
 
 
Figure 6: Time course of testosterone modulation of OPA1 expression in muscle cells. 
C2C12 cells were treated during the indicated periods of time with 10
-9
 M 
testosterone, IPA (0.001%) or maintained in DMEM (C). Western blot analyses were 
performed using anti-OPA1 antibody. β-Tubulin level is shown as loading control. The 
blots are representative of three independent experiments with comparable results. 
Densitometric quantification of the blot is shown. Averages ± S.D are given. *p < 0.05 
respect to the counterpart IPA control condition. 
 
Figure 7: Prediction of putative TFBSs of AR in murine mitochondrial genome by 
PWMScan. A) PWMs Logo for AR-binding motif sequence obtained from CIS-BP 
(M1456_1.02 Ar) and HOCOMOCO (ANDR_MOUSE.H11MO.0.A and 
ANDR_MOUSE.H11MO.1.A) databases. B) Map of the Mus Musculus (NC_005089) 
mitochondrial genome. The mouse mitochondrial DNA (mtDNA) comprises 16,299 bp. 
mtDNA forms an inner light strand (L-strand) and an outer heavy strand (H-strand) that 
encodes different genes. The H-strand, encodes 28 genes: 2 rRNAs (rRNAs 12S y 16S), 
14 tRNAs (tRNA -Phe, -Val, -Leu, -Ile, -Met, -Trp, -Asp, -Lys, Gly, -Arg, -His, -Leu, -Ser, -
Thr) and 12 polypeptides (ND1, ND2, ND3, ND4, ND4L, ND5, COX1, COX2, COX3, ATP6, 
ATP8, CytB), while the L-strand, encodes only 8 tRNAs (tRNA -Gln, -Ala, -Asn, -Cys, -Tyr, 
-Ser, -Glu, -Pro)  and a single polypeptide, ND6. Colors identify the different genes: 
rRNAs (orange), tRNAs (blue), proteins encoding subunits of the MRC complexes I 
(pink), III (light blue), IV (green), and V (red).  Non-coding region, D-loop, is represented 
by color yellow.  The gray call boxes contain the specific sequence binding sites 
predicted for the AR and their location in the genome: in red those located in H-strand, 
in blue those located in L-strand. 
Table 1: Sequences showing putative TFBSs of AR detected in the mouse mitochondrial 
genome
a 
Consensus:  brTGTTCytw 
                      RGvACAbTvTGTbCYb 




H (+) L (-) 
Score p-Value Location 
619 631 AGCCTGTTCTAT    +    1070 1.05e-04 rRNA 12S 
800 810 AATGTTCTTT - 1209 7.04e-05  
1081 1097 TGAACACTCTGAACTA + 1023 2.79e-05 tRNA-Val 
1244 1256 TGCTTGTTCTTA - 1087 9.18e-05  
2041 2051 CTTGTTCCTT + 1028 2.27e-04 rRNA 16S 
2714 2726 ACCTTGTTCCCA + 1002 1.73e-04 tRNA-Leu 
2749 2759 AGTGTTCTTT + 1134 1.25e-04 ND1 
2833 2843 TATGTACCCT - 1021 2.48e-04  
3254 3266 TATGTGTTCTTG - 1180 3.99e-05  
4154 4164 CATGTTCCTA - 1400 5.27e-06  
5326 5336 TATGTTCATT + 1139 1.13e-04 COX1 
5692 5708 TGTTCATCCTGTTCCT - 1182 1.19e-05  
6459 6471 ACTATGTTCTAT + 1008 1.64e-04 COX1 
9789 9801 ACTCTGTTCATT - 1164 4.74e-05  
10123 10135 AATCTGTTCCGT - 1080 9.70e-05  
13745 13757 TTTGTGTGCTTA - 1030 1.40e-04 ND6 
15961 15973 ACTGTGTGCTGT - 1230 2.38e-05 D-loop 
16239 16249 AATGTTCCGT + 1013 2.68e-04 D-loop 
      
a.  The numbers refer to the position of the sequences in the genome. Denoted also are the genes in 











• Testosterone induces NRF1 and 2, Tfam and TFB2M transcription factors 
expression. 
• Testosterone upregulates mitochondrial genes that encode MRC proteins. 
• H2O2 downregulates mitochondrial genes that encode MRC proteins. 
• Testosterone promotes mitochondria preservation by induction of OPA1 
expression. 
• Mouse mitochondrial genome contains putative AR binding sites. 
• Testosterone modulates directly and indirectly mitochondrial gene expression. 
 
